Previous  |  1 |  ... |  106 |  107 |  108 |  109 |  110 |  111 |  112 |  113 |  114 |  115 |  116 |  ... |  230 |  Next

Title: What is Quarantine and Isolation?

Category: International EM

Keywords: Infectious diseases, isolation, quarantine (PubMed Search)

Posted: 10/16/2014 by Jon Mark Hirshon, MPH, MD, PhD

With all the current concern about Ebola, it is important to understand what are quarantine and isolation and who can order these.

Per the Centers for Disease Control:

Federal Law allows for quarantine and isolation:

State laws allows for the enforcement of isolation and quarantine within their borders.

Bottom Line:

Show References



Title: Valproic acid toxicity

Category: Toxicology

Keywords: valproic acid (PubMed Search)

Posted: 10/16/2014 by Hong Kim, MD (Updated: 3/11/2026)

Valproic acid (VPA) is often used to treat seizure disorder and mania as a mood stabilizer. The mechanism of action involves enhancing GABA effect by preventing its degradation and slows the recovery from inactivation of neuronal Na+ channels (blockade effect).

 

VPA normally undergoes beta-oxidation (same as fatty acid metabolism) in the liver mitochondria, where VPA is transported into the mitochondria by carnitine shuttle pathway.

 

In setting of an overdose, carnitine is depleted and VPA undergoes omega-oxidation in the cytosol, resulting in a toxic metabolite.

 

Elevation NH3 occurs as the toxic metabolite inhibits the carbomyl phosphate synthase I, preventing the incorporation of NH3 into the urea cycle.

 

Signs and symptoms of acute toxicity include:

 

Laboratory abnormalities

 

Treatment: L-carnitine

Show References



Title: Valproic acid toxicity

Category: Toxicology

Keywords: Valproic acid (PubMed Search)

Posted: 10/16/2014 by Hong Kim, MD

Valproic acid (VPA) is often used to treat seizure disorder and mania as a mood stabilizer. The mechanism of action involves enhancing GABA effect by preventing its degradation and slows the recovery from inactivation of neuronal Na+ channels (blockade effect).

VPA normally undergoes beta-oxidation (same as fatty acid metabolism) in the liver mitochondria, where VPA is transported into the mitochondria by carnitine shuttle pathway.

In setting of an overdose, carnitine is depleted and VPA undergoes omega-oxidation in the cytosol, resulting in a toxic metabolite.

Elevation NH3 occurs as the toxic metabolite inhibits the carbomyl phosphate synthase I, preventing the incorporation of NH3 into the urea cycle.

Signs and symptoms of acute toxicity include:

Laboratory abnormalities

Treatment: L-carnitine

Show References



Title: Hemoglobin Threshold in Septic Shock

Category: Critical Care

Posted: 10/14/2014 by Mike Winters, MBA, MD (Updated: 3/11/2026)

Hemoglobin Threshold in Septic Shock

Show References



Title: What's the Diagnosis?

Category: Visual Diagnosis

Posted: 10/13/2014 by Haney Mallemat, MD

Question

A neck ultrasound is performed during endotracheal intubation. What is labeled "A", what is labeled "B" and what's the diagnosis?

Show Answer

Show References



Title: Kounis Syndrome (Part II)

Category: Cardiology

Posted: 10/12/2014 by Semhar Tewelde, MD (Updated: 3/11/2026)

Kounis Syndrome (Part II)

- KS can develop from multiple etiologies: hymenoptera, proteins, vasoactive amines, histamine, acetylcholine, multiple antibiotics, and various medical conditions (angioedema, serum sickness, asthma, stress-induced cardiomyopathy).

- Hypersensitivity myocarditis and KS are two cardiac entities of allergic etiology affecting the myocardium and coronary arteries, respectively. These two entities can mimic each other and can be clinical indistinguishable.

- Presence of eosinophil’s, atypical lymphocytes, and giant cells on myocardial biopsy suggests hypersensitivity myocarditis.

- There is evidence showing use of corticosteroids with vasospastic angina with evidence of allergy or the presence of symptoms refractory to high-dose vasodilators has been reported to resolve symptoms.

 

Show References



Title: Concussion treatment

Category: Airway Management

Keywords: Concussion, patient education (PubMed Search)

Posted: 10/11/2014 by Brian Corwell, MD

There is no effective pharmacologic treatment known to hasten recovery from concussion. In future pearls we will examine possible interventions that may help.

The importance of educating our patients was demonstrated in two studies looking at concussion education. Patients were separated into 2 groups. The intervention group received a booklet of information discussing common symptoms of concussion, suggested coping strategies and the likely time course of recovery. At a 3 month follow-up evaluation, the intervention group reported fewer symptoms. This was repeated in pediatric patients with similar results.

Take Home: Consider taking the time to put such an information sheet together for concussed patients seen in the ED.

Show References



Title: Pediatric Pneumonia

Category: Pediatrics

Posted: 10/10/2014 by Rose Chasm, MD (Updated: 3/11/2026)

Show References



Title: Treatment for Calcium Channel Blocker Poisoning: What's the Evidence?

Category: Toxicology

Keywords: calcium channel blocker, poisoning (PubMed Search)

Posted: 10/9/2014 by Bryan Hayes, PharmD (Updated: 10/11/2014)

In a precursor to a forthcoming international guideline on the management of calcium channel blocker poisoning, a new systematic review has been published assessing the available evidence.

A few findings from the systematic review:

Stay tuned for the international guideline coming out soon. One treatment recommendation from the new guideline, reported at the 8th European Congress on Emergency Medicine last month, is not to use glucagon.

Show References



Title: Evaluation of hydrocephalus in the ED

Category: Neurology

Keywords: Hydrocephalus, CSF shunt malfunction, ventriculomegaly, Evans' ratio (PubMed Search)

Posted: 10/8/2014 by WanTsu Wendy Chang, MD

Hydrocephalus is a disorder of cerebrospinal fluid (CSF) accumulation.  Acute obstructive hydrocephalus such as in subarachnoid hemorrhage and CSF shunt malfunction can cause a rapid rise in intracranial pressure.  Nonobstructive hydrocephalus is associated with subacute symptoms.   Clinical features of acute obstructive hydrocephalus include headache, blurred vision, papilledema, ocular palsies, nausea and vomiting, and decreased level of consciousness.

Evaluation of hydrocephalus in the ED should include neuroimaging, typically noncontrast head CT given its wide availability.  CT characteristics of hydrocephalus can be seen in Figure 1: ventriculomegaly with dilated 3rd ventricle, dilated 4th ventricle, and presence of temporal horns.

When evaluating patients with pre-existing hydrocephalus for worsening symptoms, such as in the evaluation of CSF shunt malfunctions, it is helpful to compare the head CT or MRI for interval ventricular enlargement.  Two simple measurements can be taken on a CT or MRI for objective comparisons (Figure 2).

  • Evans' ratio = A/B = Maximum width of frontal horns (A) divided by maximum width of inner skull (B) at the same CT/MRI level

  • C = Width of 3rd ventricle

Use of acetazolamide to decrease CSF production is not effective in long-term treatment of hydrocephalus.  About 75% of patients with hydrocephalus require CSF shunt placement.

Show References

Attachments



Title: New UMEM Pearls App!

Category: Misc

Keywords: app pearls apple google (PubMed Search)

Posted: 10/7/2014 by Kevin Hamilton

We are proud to announce the release of our new UMEM Pearls App, now available in the Apple App Store and the Google Play Marketplace! You will now be able to pull down pearl content for offline viewing, in addition to having all of the pearls in searchable format available on your mobile devices.

Click either of the following links on your mobile device to download your Pearls App today!

Get it on Google Play!

 

Get it on Apple App Store!



Title: First PROCESS, now ARISE and resuscitate your septic patients

Category: Critical Care

Posted: 10/7/2014 by John Greenwood, MD (Updated: 10/7/2014)

The ARISE Trial

Early, aggressive resuscitation and attention to detail are essential element of managing critically ill patients.  This past week the ARISE trial was published - a 2nd large, randomized control study to examine the benefit of protocolized vs. usual care in patients with severe sepsis and septic shock. 

What were the main findings?  After enrolling 1,600 patients who presented to the ED in severe sepsis or septic shock:

Bottom Line:  Resuscitation goals for the patient with septic shock should include:

Additional therapeutic goals should be made on a patient by patient basis.  Reassess your patient frequently, pay attention to the details, and you will improve your patient’s mortality.

 

Suggested Reading

  1. The ARISE Investigators and the ANZICS Clinical Trials Group.  Goal-Directed Resuscitation for Patients with Early Septic Shock. N Engl J Med. 2014. [PubMed Link]
  2. Wessex ICS: The Bottom Line Review

Follow Me on Twitter: @JohnGreenwoodMD



Title: What's the Diagnosis? By Dr. Ari Kestler and Dr. Ashley Strobel

Category: Visual Diagnosis

Posted: 10/6/2014 by Haney Mallemat, MD

Question

7d old child presents with difficulty feeding,vomiting one time, and now with intermittent apneic episodes. What's the diagnosis? (Careful....this one is tricky!)

Show Answer

Show References



Title: Visual Diagnosis Pediatrics: Case thanks to Ari Kestler MD (@KestlerMD) and Haney Mallemat MD (@CriticalCareNow)

Category: Pediatrics

Keywords: non-accidental trauma, clavicle fracture, neonate, pediatrics, abuse (PubMed Search)

Posted: 10/4/2014 by Ashley Strobel, MD

Question

Q: What is wrong with this baby? And what Dx should you entertain?

Previously healthy 7d old presents after difficulty feeding, one episode of vomiting and now with intermittent apneic episodes.

 

Show Answer

Show References

Attachments



Title: Kounis Syndrome (Part I)

Category: Cardiology

Posted: 10/4/2014 by Semhar Tewelde, MD

Kounis Syndrome (Part I)

- Kounis & Zavras (1991) described the syndrome of allergic angina and allergic myocardial infarction, currently known as Kounis syndrome (KS). Braunwald (1998) noted vasospastic angina can be induced by allergic reactions, with mediators such as histamine and leukotrienes acting on coronary vascular smooth muscle.

- Two subtypes have been described: type I, occurring in patients without predisposing factors for CAD often caused by coronary artery spasm and type II, occurring with angiographic evidence of coronary disease when the allergic events induce plaque erosion or rupture.

- This syndrome has been reported in association with a variety of medical conditions, environmental exposures, and medication exposures. Entities such as Takotsubo cardiomyopathy, drug-eluted stent thrombosis, and coronary allograft vasculopathy also appear to be associated with this syndrome.

-  Clinical presentation includes: symptoms and signs of an allergic reaction and acute coronary syndrome: chest pain, dyspnea, faintness, nausea, vomiting, syncope, pruritus, urticaria, diaphoresis, pallor, palpitations, hypotension, and bradycardia. 

Show References



Title: Beta-Lactams in Critically Ill Patients: Current Dosing May be Inadequate

Category: Pharmacology & Therapeutics

Keywords: beta-lactam, piperacillin/tazobactam, critically ill (PubMed Search)

Posted: 10/4/2014 by Bryan Hayes, PharmD (Updated: 10/4/2014)

Beta-lactam antimicrobials (penicillins, cephalosporins, and carbapenems) are frequently used for empiric and targeted therapy in critically ill patients. They display time-dependent killing, meaning the time the antibiotic concentration is above the minimin inhibitory concentration (MIC) is associated with improved efficacy.

Two new pharmacodynamic/pharmacokinetic studies suggest that current beta-lactam antimicrobial dosing regimens may be inadequate.

Antimicrobial dosing in critically ill patients is complex. Current dosing of beta-lactams may be inadequate and needs to be studied further with relation to clinical outcomes.

Show References



Title: Influenza- Why Worry?

Category: International EM

Keywords: Influenza (PubMed Search)

Posted: 10/1/2014 by Jon Mark Hirshon, MPH, MD, PhD (Updated: 10/29/2014)

INFLUENZA

What is it?

 

Why do we care about influenza?

 

Bottom line



Title: Lily of the Valley

Category: Toxicology

Keywords: Digoxin, Cardioactive Steroids, Digitoxin, Digoxin-specific Fab Fragment (PubMed Search)

Posted: 10/1/2014 by Kishan Kapadia, DO

Cardioactive steroids are among the many treatments used for CHF, and for the control of ventricular response rate in atrial tachydysrhythmias. There are many sources of cardioactive steroids:

Pharmaceutial: Digoxin, Digitoxin

Plants: Oleander, Yellow Oleander, Foxglove, Lily of the Valley, Dogbane, Red Squill

Animal: Bufo marinus toad

It is a potent Na+-K+-ATPase inhibitor and can lead to hyperkalemia in acute ingestion with associated signs and symptoms of N/V, abdominal pain, bradycardia and possibly, hypotension.

Toxicity should be suspected with bidirectional ventricular tachycardia or atrial tachycardia with high-degree AV block

Therapeutic range of digoxin of 0.5 - 2.0 ng/mL is helpful but not a sole indicator of toxicity

Indication for antidote (Digoxin-specific Antibody Fragments) include:

1) Digoxin-related life-threatening dysrhythma

2) Serum K+ > 5.0 mEq/L in acute ingestion

3) Serum digoxin concentration >15ng/mL at any time, or >10 ng/mL 6 hours postingestion

4) Ingestion of 10 mg in adult; 4 mg in pediatric

5) Poisoning by non-digoxin cardioactive steroid

Show References



Title: Back 2 Basics Series: Need More Squeeze - Part II Inotropes

Category: Critical Care

Posted: 9/30/2014 by Haney Mallemat, MD (Updated: 10/1/2014)

The last Back to the Basics post discussed the use of vasopressors to improve hemodynamics by increasing arterial (and venous) tone. This time we’ll discuss the use of agents to increase inotropy for patients with severe systolic dysfunction / failure.

Dobutamine: a direct b1 and b2-receptors agonist. It has no peripheral vasoconstrictor properties, so if blood pressure increases it occurs secondary to increased cardiac output. Unfortunately, blood pressure may be decreased in some patients due to its peripheral vasodilatory effects; in these cases it may need to be used with a vasopressor.

Milrinone: augments contractility by increasing intracellular Ca levels via cellular phosphodiesterase inhibition. Because it does not work on beta-receptors, it might be preferred for patients taking beta-blockers requiring inotropic support. It may cause peripheral vasodilation and hypotension, but this may be a benefit if pulmonary artery pressure is elevated as reductions in pulmonary artery pressure lead to improvements in right ventricular function. It has a long-half life and should be avoided in patients with renal impairment.

Dopamine: chemical precursor to norepinephrine and technically a vasopressor. At moderate doses (3-10 mcg/kg/min) it works on beta-receptors to increase myocyte contractility. At higher doses works primarily as a vasopressor, which may reduce cardiac output due to higher afterload.

Norepinephrine/epinephrine: has alpha and beta properties that lead to increased peripheral vasoconstriction, but also increases inotropy and chronotropy (faster heart rate)

Show References



Title: What's the Diagnosis? Case by Dr. Maite Huis in 't Veld

Category: Visual Diagnosis

Posted: 9/29/2014 by Haney Mallemat, MD (Updated: 10/1/2014)

Question

Person presents with painless vision loss after seeing flashes of light. Ultrasound is below. What's the diagnosis?

Show Answer

Show References



Previous  |  1 |  ... |  106 |  107 |  108 |  109 |  110 |  111 |  112 |  113 |  114 |  115 |  116 |  ... |  230 |  Next